Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Cell Death and Differentiation|March 31, 2021
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic functionKirsteen J Campbell, Susan M Mason, Matthew L Winder, et al.
Cell Death & Disease|January 18, 2018
MCL-1 is a prognostic indicator and drug target in breast cancerKirsteen J Campbell, Sandeep Dhayade, Nicola Ferrari, et al.
Oncogene|May 23, 2012
KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammalsS Moleirinho, N Chang, A H Sims, et al.
Pediatrics|February 17, 2005
Pediatric Fabry diseaseMarkus Ries, Surya Gupta, David F Moore, et al.
Cancer Research|December 18, 2021
Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC InhibitorsHenry Beetham, Billie G C Griffith, Olga Murina, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2016
Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic TumorsDamir Varešlija, Jean McBryan, Ailís Fagan, et al.
Cancer Research|January 14, 2018
Kindlin-1 Promotes Pulmonary Breast Cancer MetastasisSana Sarvi, Hitesh Patel, Jun Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2018
Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast CancerElspeth Ward, Damir Varešlija, Sara Charmsaz, et al.
Oncotarget|February 18, 2016
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapyHelen Creedon, Laura Gómez-Cuadrado, Žygimantė Tarnauskaitė, et al.
Pageof 37